Antithrombin III supplementation reduces heparin requirement and platelet loss during hemodialysis of patients with fulminant hepatic failure
Version of Record online: 5 DEC 2005
Copyright © 1991 American Association for the Study of Liver Diseases
Volume 14, Issue 2, pages 251–256, August 1991
How to Cite
Langley, P. G., Keays, R., Hughes, R. D., Forbes, A., Delvos, U. and Williams, R. (1991), Antithrombin III supplementation reduces heparin requirement and platelet loss during hemodialysis of patients with fulminant hepatic failure. Hepatology, 14: 251–256. doi: 10.1002/hep.1840140208
- Issue online: 5 DEC 2005
- Version of Record online: 5 DEC 2005
- Manuscript Accepted: 9 MAR 1991
- Manuscript Received: 26 NOV 1990
- Behringwerke Ag
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.